For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK's long-acting asthma drug halved attacks in phase 3, backing up blockbuster hopes “Today’s data build on the body of evidence supporting depemokimab as an ultra-long-acting treatment and ...